Moreover, a high ADRA2C expression level was associated with a favorable PFI in GBMLGG (HR=0.58, p<0.001) and UVM (HR=0.36, p=0.012) (Figures 3J and 3K), while a high ADRA2C expression level was correlated with a poor PFI in ACC (HR=2.39, p=0.009), and esophageal squamous cell carcinoma (ESCC) (HR=2.12, p=0.028) (Figures 3H and 3I). Here, ADRA2C is linked to adrenal cortex carcinoma.